GlassScriptPhysician profile
Kyle John Kraber
NPI 1568786838
$2,400.73
in general payments reported to CMS, 2019-2025
23 companies · $19.98 in 2025
The $19.98 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $657 · 2022: $823 · 2023: $744 · 2024: $157 · 2025: $19.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911 · Education: $9.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.08 |
| Education | $9.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $676.64 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Boston Scientific Corporation | $279.05 | 2021-2024 | Ams 700 |
| Clarus Therapeutics INC. | $172.55 | 2021 | |
| Tolmar, INC. | $147.10 | 2023 | |
| Merck Sharp & Dohme LLC | $146.29 | 2021-2023 | Lynparza, Keytruda |
| Endo Pharmaceuticals INC. | $146.09 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $125.26 | 2023 | |
| Bioxcel Therapeutics, INC. | $125.00 | 2023 | Igalmi |
| Abbvie INC. | $95.56 | 2022-2023 | |
| Genzyme Corporation | $69.44 | 2021-2022 | |
| Janssen Biotech, INC. | $51.51 | 2022-2024 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $48.50 | 2023 | |
| Halozyme INC | $48.39 | 2023 | |
| Srs Medical Systems, INC. | $42.61 | 2023 | Urocuff |
| Astellas Pharma US INC | $40.53 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $39.63 | 2022 | |
| 180 Medical, INC. | $27.59 | 2023 | |
| Myriad Genetic Laboratories, INC. | $25.29 | 2022 | |
| Sumitomo Pharma America, INC. | $23.97 | 2023 | Gemtesa |
| Axonics, INC. | $21.48 | 2022 | |
| Medtronic, INC. | $19.98 | 2025 | Altaviva |
| Koelis INC. | $15.12 | 2023 | |
| Mission Pharmacal Company | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kraber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.